Literature DB >> 32602278

Metformin Preserves Peripheral Nerve Damage with Comparable Effects to Alpha Lipoic Acid in Streptozotocin/High-Fat Diet Induced Diabetic Rats.

Sun Hee Kim1, Tae Sun Park1, Heung Yong Jin2.   

Abstract

BACKGROUND: Metformin is widely marketed medication for the treatment of diabetes, but its pharmacological effect on diabetic peripheral neuropathy remains unclear. In this study, the effect of metformin on peripheral nerves in diabetic rats was investigated using diverse neuronal parameters of nerve fibers.
METHODS: Rats were assigned to one of four groups (n=7 to 10 per group): normal, diabetes mellitus (DM), DM+metformin (100 mg/kg), and DM+alpha lipoic acid (ALA, 100 mg/kg). DM was induced by streptozotocin/high-fat diet (STZ/HFD). After 12 weeks, the sensory thresholds to mechanical and heat stimuli were assessed. Repeated sensory tests, immunofluorescence microscopic comparison of peripheral nerves, and biochemical blood analysis were performed after 24 weeks.
RESULTS: Both DM+metformin and DM+ALA groups showed similar trends to diverse sensory tests at 24 weeks compared to DM group although the degree of change were different according to the stimulated senses. There was no significant difference in the comparison of the intraepidermal nerve fiber density (IENFD) of peripheral nerves between the DM+metformin and DM+ALA groups (11.83±0.07 fibers/mm vs. 12.37±1.82 fibers/mm, respectively). Both groups showed preserved IENFD significantly compared with DM group (8.46±1.98 fibers/mm, P<0.05). Sciatic nerve morphology of the experimental animals showed a similar trend to the IENFD, with respect to axonal diameter, myelin sheath thickness, and myelinated fiber diameter.
CONCLUSION: Metformin has beneficial pharmacological effects on the preservation of peripheral nerves in diabetic rats and its effects are comparable to those of ALA.
Copyright © 2020 Korean Diabetes Association.

Entities:  

Keywords:  Diabetes mellitus; Metformin; Peripheral nerves; Thioctic acid; Vitamin B12

Year:  2020        PMID: 32602278     DOI: 10.4093/dmj.2019.0190

Source DB:  PubMed          Journal:  Diabetes Metab J        ISSN: 2233-6079            Impact factor:   5.376


  5 in total

1.  Metformin Preserves Peripheral Nerve Damage with Comparable Effects to Alpha Lipoic Acid in Streptozotocin/High-Fat Diet Induced Diabetic Rats (Diabetes Metab J 2020;44:842-53).

Authors:  Bo Kyung Koo
Journal:  Diabetes Metab J       Date:  2021-01-22       Impact factor: 5.376

2.  Metformin Preserves Peripheral Nerve Damage with Comparable Effects to Alpha Lipoic Acid in Streptozotocin/High-Fat Diet Induced Diabetic Rats (Diabetes Metab J 2020;44:842-53).

Authors:  Sun Hee Kim; Tae Sun Park; Heung Yong Jin
Journal:  Diabetes Metab J       Date:  2021-01-22       Impact factor: 5.376

3.  Impacts of statin and metformin on neuropathy in patients with type 2 diabetes mellitus: Korean Health Insurance data.

Authors:  Hong Ki Min; Se Hee Kim; Jong Han Choi; Kyomin Choi; Hae-Rim Kim; Sang-Heon Lee
Journal:  World J Clin Cases       Date:  2021-11-26       Impact factor: 1.337

Review 4.  Is metformin a possible treatment for diabetic neuropathy?

Authors:  Juechun Wei; Yanling Wei; Meiyan Huang; Peng Wang; Shushan Jia
Journal:  J Diabetes       Date:  2022-09-18       Impact factor: 4.530

5.  Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system.

Authors:  Sarah Demaré; Asha Kothari; Nigel A Calcutt; Paul Fernyhough
Journal:  Expert Rev Neurother       Date:  2020-12-04       Impact factor: 4.287

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.